The mortality induced by infections in onco-hematological patients is abnormally high at the acute phase of septic shock. Consequently, it is important to detect the population with a high risk of short term mortality among patients with a septic shock. The aim of this study is the evaluation of predictive proteic profile on the short term mortality in the acute phase of septic shock in cancer patients.
Method: Monocentric prospective study with diagnostic and prognostic expectations. Primary objective: Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock. Secondary objective: Research of clinical and biological prognostic factors.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
60
An extra blood sample is required to determine the plasmatic proteic profile used to identify one or several signatures which are correlated to the clinical evolution (mortality at D30).
Institut Paoli-Calmettes
Marseille, France
Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock.
Time frame: 1 month
Research of clinical and biological prognostic factors.
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.